Pyxis Oncology, Inc. (PYXS)
3.51
-0.38
(-9.77%)
USD |
NASDAQ |
Sep 09, 15:46
Pyxis Oncology Total Assets (Quarterly) : 54.92M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.92M |
| March 31, 2026 | 64.30M |
| December 31, 2025 | 94.52M |
| September 30, 2025 | 105.60M |
| June 30, 2025 | 123.22M |
| March 31, 2025 | 135.87M |
| December 31, 2024 | 157.18M |
| September 30, 2024 | 195.31M |
| June 30, 2024 | 208.39M |
| March 31, 2024 | 220.22M |
| December 31, 2023 | 173.73M |
| September 30, 2023 | 186.69M |
| Date | Value |
|---|---|
| June 30, 2023 | 175.23M |
| March 31, 2023 | 182.80M |
| December 31, 2022 | 211.38M |
| September 30, 2022 | 223.90M |
| June 30, 2022 | 242.56M |
| March 31, 2022 | 252.70M |
| December 31, 2021 | 280.02M |
| September 30, 2021 | 139.49M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 10.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 43.48M |
| Shareholders Equity (Quarterly) | 11.44M |
| Debt to Equity Ratio | 1.559 |
| Current Ratio | 1.337 |
| Net Debt Paydown Yield | 0.21% |